These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37874260)
1. Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis. Robin F; Chappard D; Leroyer P; Latour C; Mabilleau G; Monbet V; Cavey T; Horeau M; Derbré F; Roth MP; Ropert M; Guggenbuhl P; Loréal O FASEB J; 2023 Nov; 37(11):e23245. PubMed ID: 37874260 [TBL] [Abstract][Full Text] [Related]
2. Bone status in a mouse model of genetic hemochromatosis. Guggenbuhl P; Fergelot P; Doyard M; Libouban H; Roth MP; Gallois Y; Chalès G; Loréal O; Chappard D Osteoporos Int; 2011 Aug; 22(8):2313-9. PubMed ID: 20976594 [TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830 [TBL] [Abstract][Full Text] [Related]
4. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin. Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138 [TBL] [Abstract][Full Text] [Related]
5. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P Bone; 2022 Nov; 164():116511. PubMed ID: 35933095 [TBL] [Abstract][Full Text] [Related]
6. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. Corradini E; Schmidt PJ; Meynard D; Garuti C; Montosi G; Chen S; Vukicevic S; Pietrangelo A; Lin HY; Babitt JL Gastroenterology; 2010 Nov; 139(5):1721-9. PubMed ID: 20682319 [TBL] [Abstract][Full Text] [Related]
7. Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice. Cavey T; Latour C; Island ML; Leroyer P; Guggenbuhl P; Coppin H; Roth MP; Bendavid C; Brissot P; Ropert M; Loréal O FASEB J; 2019 Oct; 33(10):11072-11081. PubMed ID: 31298936 [TBL] [Abstract][Full Text] [Related]
8. Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss. Doyard M; Chappard D; Leroyer P; Roth MP; Loréal O; Guggenbuhl P PLoS One; 2016; 11(2):e0148292. PubMed ID: 26829642 [TBL] [Abstract][Full Text] [Related]
9. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355 [TBL] [Abstract][Full Text] [Related]
10. Intracellular labile iron is a key regulator of hepcidin expression and iron metabolism. Li Y; Ouyang Q; Chen Z; Chen W; Zhang B; Zhang S; Cong M; Xu A Hepatol Int; 2023 Jun; 17(3):636-647. PubMed ID: 36512269 [TBL] [Abstract][Full Text] [Related]
11. HJV and HFE Play Distinct Roles in Regulating Hepcidin. Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116 [TBL] [Abstract][Full Text] [Related]
12. Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis. Simão M; Camacho A; Ostertag A; Cohen-Solal M; Pinto IJ; Porto G; Hang Korng E; Cancela ML PLoS One; 2018; 13(11):e0207441. PubMed ID: 30427936 [TBL] [Abstract][Full Text] [Related]
13. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload? Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887 [TBL] [Abstract][Full Text] [Related]
14. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Corradini E; Rozier M; Meynard D; Odhiambo A; Lin HY; Feng Q; Migas MC; Britton RS; Babitt JL; Fleming RE Gastroenterology; 2011 Nov; 141(5):1907-14. PubMed ID: 21745449 [TBL] [Abstract][Full Text] [Related]
15. HFE and ALK3 act in the same signaling pathway. Traeger L; Schnittker J; Dogan DY; Oguama D; Kuhlmann T; Muckenthaler MU; Krijt J; Urzica EI; Steinbicker AU Free Radic Biol Med; 2020 Nov; 160():501-505. PubMed ID: 32861780 [TBL] [Abstract][Full Text] [Related]
16. Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia. Xiao X; Moschetta GA; Xu Y; Fisher AL; Alfaro-Magallanes VM; Dev S; Wang CY; Babitt JL Blood; 2023 Jan; 141(4):422-432. PubMed ID: 36322932 [TBL] [Abstract][Full Text] [Related]
17. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Ryan JD; Ryan E; Fabre A; Lawless MW; Crowe J Hepatology; 2010 Oct; 52(4):1266-73. PubMed ID: 20658468 [TBL] [Abstract][Full Text] [Related]
18. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Ramos E; Kautz L; Rodriguez R; Hansen M; Gabayan V; Ginzburg Y; Roth MP; Nemeth E; Ganz T Hepatology; 2011 Apr; 53(4):1333-41. PubMed ID: 21480335 [TBL] [Abstract][Full Text] [Related]
19. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097 [TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies. Neves JV; Olsson IA; Porto G; Rodrigues PN Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G525-9. PubMed ID: 20110460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]